Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid.

Unal, Gokhan; Turan, Bahadir; Balcioglu, Yasin Hasan

Unal, Gokhan; Turan, Bahadir; Balcioglu, Yasin Hasan.

Unal G; Department of Pharmacology, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey.
Turan B; Autism, Mental Special Needs and Rare Diseases Department, Republic of Turkey Ministry of Health, Ankara, Turkey.
Balcioglu YH; Department of Psychiatry, Bakirkoy Prof Mazhar Osman Training and Research Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul 34147, Turkey. Electronic address: yhasanbalcioglu@gmail.com.

Med Hypotheses ; 143: 109891, 2020 10.

Article in English | MEDLINE | ID: covidwho-401501

Subject(s)

Coronavirus Infections; Coronavirus; Pandemics; Pneumonia, Viral; Valproic Acid; Antimanic Agents; Betacoronavirus; COVID-19; Humans; Lithium; SARS-CoV-2

Keywords

COVID-19; Cytokines; Immunomodulation; Immunopharmacology; Mood stabilizers; Valproic acid; Viral replication

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Valproic Acid / Coronavirus Infections / Coronavirus / Pandemics Limits: Humans Language: English Journal: Med Hypotheses Year: 2020 Document Type: Article Affiliation country: J.mehy.2020.109891

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google